|
|
| | PF-00299804 Basic information |
| Product Name: | PF-00299804 | | Synonyms: | Dacomitinib Monhydrate;PF-00299804-3;PF-804;DACOMITINIB MONHYDRAT;(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide hydrate (1:1);(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide,hydrate;PF-00299804 dacomitinib;Dacomitinib hydrate | | CAS: | 1042385-75-0 | | MF: | C24H27ClFN5O3 | | MW: | 487.9542832 | | EINECS: | | | Product Categories: | | | Mol File: | 1042385-75-0.mol |  |
| | PF-00299804 Chemical Properties |
| | PF-00299804 Usage And Synthesis |
| Uses | PF299804 is a potent, irreversible pan-ErbB inhibitor against ErbB1, ErbB2 and ErbB4 with IC50 of 6 nM, 45.7 nM and 73.7 nM, respectively. |
| | PF-00299804 Preparation Products And Raw materials |
|